Summary Aeolus Pharmaceuticals Inc (Aeolus) is a biopharmaceutical company that is developing a platform of new compounds for use in cancer, infectious diseases, central nervous system (CNS) diseases, fibrosis and biodefense. The company’s lead product, AEOL 10150 is a broad catalytic antioxidant particularly designed to neutralize reactive oxygen and nitrogen species. AEOL-10150 compound is funded by the U.S. Government aimed at developing as a medical countermeasure against national securit...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.